doi: 10.1089/ars.2005.7.1040 126 Babaei-AbrakiSKaramaliFNasr-EsfahaniMH
Efficacy and Safety The therapeutic potential and safety profile of Ipamorelin are evaluated in animal models of various diseases or conditions
Methods We searched for eligible trials published in PubMed (last search in February 2015) by using the following search algorithm: (Glucagon-like peptide-1 receptor agonists OR exenatide OR liraglutide OR lixisenatide OR albiglutide OR dulaglutide) AND (side effects OR adverse effects OR safety OR gastrointestinal OR pancreas OR liver OR cardiovascular OR skin OR allergy OR angioedema OR immune system OR renal OR kidney OR infection OR central nervous system OR blood OR malignancy OR cancer) The search was limited by the following criteria: - Published in the English language
This passive targeting mechanism still can be enhanced to make a favourable delivery of antioxidants to the cancer cells making it more efficient
Lima TI, Guimares D, Sponton CH, Bajgelman MC, Palameta S, Toscaro JM, et al
It helps neutralize harmful free radicals and reduce oxidative stress, which is linked to various chronic diseases and the aging process
